The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Viral Vectors and Plasmid DNA Manufacturing-Global Market Insights and Sales Trends 2025
Synopsis
The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.
The global Viral Vectors and Plasmid DNA Manufacturing market size is expected to reach US$ 1961.9 million by 2029, growing at a CAGR of 18.0% from 2023 to 2029. The market is mainly driven by the significant applications of Viral Vectors and Plasmid DNA Manufacturing in various end use industries. The expanding demands from the Cancers, Inherited Disorders, Viral Infections and Others, are propelling Viral Vectors and Plasmid DNA Manufacturing market. Plasmid DNA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Viral Vectors segment is estimated at % CAGR for the next seven-year period.
Global Viral Vectors and Plasmid DNA Manufacturing key players include BioReliance, Oxford BioMedica, UniQure, Cobra Biologics, etc. Global top four manufacturers hold a share over 45%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific, and Europe, both have a share over 40 percent.
In terms of product, Viral Vectors is the largest segment, with a share about 80%. And in terms of application, the largest application is Cancers, followed by Inherited Disorders, Viral Infections , etc.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Viral Vectors and Plasmid DNA Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Viral Vectors and Plasmid DNA Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Viral Vectors and Plasmid DNA Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Viral Vectors and Plasmid DNA Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Viral Vectors and Plasmid DNA Manufacturing covered in this report include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm and FUJIFILM Diosynth Biotechnologies, etc.
The global Viral Vectors and Plasmid DNA Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
Global Viral Vectors and Plasmid DNA Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Viral Vectors and Plasmid DNA Manufacturing market, Segment by Type:
Plasmid DNA
Viral Vectors
Global Viral Vectors and Plasmid DNA Manufacturing market, by Application
Cancers
Inherited Disorders
Viral Infections
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Viral Vectors and Plasmid DNA Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.
The global Viral Vectors and Plasmid DNA Manufacturing market size is expected to reach US$ 1961.9 million by 2029, growing at a CAGR of 18.0% from 2023 to 2029. The market is mainly driven by the significant applications of Viral Vectors and Plasmid DNA Manufacturing in various end use industries. The expanding demands from the Cancers, Inherited Disorders, Viral Infections and Others, are propelling Viral Vectors and Plasmid DNA Manufacturing market. Plasmid DNA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Viral Vectors segment is estimated at % CAGR for the next seven-year period.
Global Viral Vectors and Plasmid DNA Manufacturing key players include BioReliance, Oxford BioMedica, UniQure, Cobra Biologics, etc. Global top four manufacturers hold a share over 45%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific, and Europe, both have a share over 40 percent.
In terms of product, Viral Vectors is the largest segment, with a share about 80%. And in terms of application, the largest application is Cancers, followed by Inherited Disorders, Viral Infections , etc.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Viral Vectors and Plasmid DNA Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Viral Vectors and Plasmid DNA Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Viral Vectors and Plasmid DNA Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Viral Vectors and Plasmid DNA Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Viral Vectors and Plasmid DNA Manufacturing covered in this report include BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector, MolMed, MassBiologics, Richter-Helm and FUJIFILM Diosynth Biotechnologies, etc.
The global Viral Vectors and Plasmid DNA Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
Global Viral Vectors and Plasmid DNA Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Viral Vectors and Plasmid DNA Manufacturing market, Segment by Type:
Plasmid DNA
Viral Vectors
Global Viral Vectors and Plasmid DNA Manufacturing market, by Application
Cancers
Inherited Disorders
Viral Infections
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Viral Vectors and Plasmid DNA Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Viral Vectors and Plasmid DNA Manufacturing
1.1 Viral Vectors and Plasmid DNA Manufacturing Market Overview
1.1.1 Viral Vectors and Plasmid DNA Manufacturing Product Scope
1.1.2 Viral Vectors and Plasmid DNA Manufacturing Market Status and Outlook
1.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2018-2029)
1.4 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Region (2018-2023)
1.5 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Viral Vectors and Plasmid DNA Manufacturing Market Size (2018-2029)
1.6.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size (2018-2029)
1.6.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size (2018-2029)
1.6.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size (2018-2029)
1.6.4 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size (2018-2029)
1.6.5 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size (2018-2029)
2 Viral Vectors and Plasmid DNA Manufacturing Market by Type
2.1 Introduction
2.1.1 Plasmid DNA
2.1.2 Viral Vectors
2.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Type (2018-2023)
2.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Viral Vectors and Plasmid DNA Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Viral Vectors and Plasmid DNA Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Breakdown by Type (2018-2029)
3 Viral Vectors and Plasmid DNA Manufacturing Market Overview by Application
3.1 Introduction
3.1.1 Cancers
3.1.2 Inherited Disorders
3.1.3 Viral Infections
3.1.4 Others
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Application (2018-2023)
3.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Viral Vectors and Plasmid DNA Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Viral Vectors and Plasmid DNA Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Breakdown by Application (2018-2029)
4 Viral Vectors and Plasmid DNA Manufacturing Competition Analysis by Players
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2022)
4.3 Date of Key Players Enter into Viral Vectors and Plasmid DNA Manufacturing Market
4.4 Global Top Players Viral Vectors and Plasmid DNA Manufacturing Headquarters and Area Served
4.5 Key Players Viral Vectors and Plasmid DNA Manufacturing Product Solution and Service
4.6 Competitive Status
4.6.1 Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BioReliance
5.1.1 BioReliance Profile
5.1.2 BioReliance Main Business
5.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.1.4 BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.1.5 BioReliance Recent Developments
5.2 Cobra Biologics
5.2.1 Cobra Biologics Profile
5.2.2 Cobra Biologics Main Business
5.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.2.4 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.2.5 Cobra Biologics Recent Developments
5.3 Oxford BioMedica
5.3.1 Oxford BioMedica Profile
5.3.2 Oxford BioMedica Main Business
5.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.3.4 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.3.5 UniQure Recent Developments
5.4 UniQure
5.4.1 UniQure Profile
5.4.2 UniQure Main Business
5.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.4.4 UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.4.5 UniQure Recent Developments
5.5 FinVector
5.5.1 FinVector Profile
5.5.2 FinVector Main Business
5.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.5.4 FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.5.5 FinVector Recent Developments
5.6 MolMed
5.6.1 MolMed Profile
5.6.2 MolMed Main Business
5.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.6.4 MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.6.5 MolMed Recent Developments
5.7 MassBiologics
5.7.1 MassBiologics Profile
5.7.2 MassBiologics Main Business
5.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.7.4 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.7.5 MassBiologics Recent Developments
5.8 Richter-Helm
5.8.1 Richter-Helm Profile
5.8.2 Richter-Helm Main Business
5.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.8.4 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.8.5 Richter-Helm Recent Developments
5.9 FUJIFILM Diosynth Biotechnologies
5.9.1 FUJIFILM Diosynth Biotechnologies Profile
5.9.2 FUJIFILM Diosynth Biotechnologies Main Business
5.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.9.4 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
5.10 Lonza
5.10.1 Lonza Profile
5.10.2 Lonza Main Business
5.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.10.4 Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.10.5 Lonza Recent Developments
5.11 Aldevron
5.11.1 Aldevron Profile
5.11.2 Aldevron Main Business
5.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.11.4 Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.11.5 Aldevron Recent Developments
5.12 Eurogentec
5.12.1 Eurogentec Profile
5.12.2 Eurogentec Main Business
5.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.12.4 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.12.5 Eurogentec Recent Developments
5.13 Cell and Gene Therapy Catapult
5.13.1 Cell and Gene Therapy Catapult Profile
5.13.2 Cell and Gene Therapy Catapult Main Business
5.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.13.4 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.13.5 Cell and Gene Therapy Catapult Recent Developments
5.14 Biovian
5.14.1 Biovian Profile
5.14.2 Biovian Main Business
5.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.14.4 Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.14.5 Biovian Recent Developments
5.15 Thermo Fisher Scientific (Brammer Bio)
5.15.1 Thermo Fisher Scientific (Brammer Bio) Profile
5.15.2 Thermo Fisher Scientific (Brammer Bio) Main Business
5.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.15.4 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments
5.16 VGXI
5.16.1 VGXI Profile
5.16.2 VGXI Main Business
5.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.16.4 VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.16.5 VGXI Recent Developments
5.17 PlasmidFactory
5.17.1 PlasmidFactory Profile
5.17.2 PlasmidFactory Main Business
5.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Products, Services and Solutions
5.17.4 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) & (2018-2023)
5.17.5 PlasmidFactory Recent Developments
6 North America
6.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Viral Vectors and Plasmid DNA Manufacturing Market Dynamics
11.1 Viral Vectors and Plasmid DNA Manufacturing Industry Trends
11.2 Viral Vectors and Plasmid DNA Manufacturing Market Drivers
11.3 Viral Vectors and Plasmid DNA Manufacturing Market Challenges
11.4 Viral Vectors and Plasmid DNA Manufacturing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
